BROMOCRIPTINE IN THE MANAGEMENT OF END OF DOSE DETERIORATION IN PARKINSONS-DISEASE

被引：12
|
作者：
GRIMES, JD
KING, DB
KOFMAN, OS
MOLINANEGRO, P
WILSON, AF
BOUCHARD, S
机构：
[1] NOTRE DAME HOSP, MONTREAL, QUEBEC, CANADA
[2] SANDOZ CANADA, MONTREAL, QUEBEC, CANADA
[3] ROYAL ALEXANDRA HOSP, EDMONTON, ALBERTA, CANADA
[4] VICTORIA GEN HOSP, HALIFAX B3H 2Y9, NS, CANADA
[5] OTTAWA CIVIC HOSP, OTTAWA K1Y 4E9, ONTARIO, CANADA
[6] MT SINAI HOSP, TORONTO M5G 1X5, ONTARIO, CANADA
来源：
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES | 1984年 / 11卷 / 04期
关键词：
D O I：
10.1017/S0317167100045996
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：452 / 456
页数：5
相关论文
共 50 条
  • [31] BROMOCRIPTINE - PROBLEMS WITH LOW-DOSE DENOVO THERAPY IN PARKINSONS-DISEASE
    GRIMES, JD
    DELGADO, MR
    CLINICAL NEUROPHARMACOLOGY, 1985, 8 (01) : 73 - 77
  • [32] LOW-DOSE BROMOCRIPTINE ADDED TO LEVODOPA IN THE TREATMENT OF PARKINSONS-DISEASE
    MASSETANI, R
    PICCINI, P
    MURRI, L
    MURATORIO, A
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1989, 46 (02): : 210 - 215
  • [33] MOOD CHANGES ASSOCIATED WITH END-OF-DOSE DETERIORATION IN PARKINSONS-DISEASE - A CONTROLLED-STUDY
    CANTELLO, R
    GILLI, M
    RICCIO, A
    BERGAMASCO, B
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1986, 49 (10): : 1182 - 1190
  • [34] THE INFLUENCE OF LEVODOPA IN THE PHARMACOKINETICS OF BROMOCRIPTINE IN PARKINSONS-DISEASE
    RABEY, JM
    OBERMAN, Z
    SCHARF, M
    ISAKOV, A
    BAR, M
    GRAFF, E
    CLINICAL NEUROPHARMACOLOGY, 1989, 12 (05) : 440 - 447
  • [35] THE INFLUENCE OF BROMOCRIPTINE ON THE PHARMACOKINETICS OF LEVODOPA IN PARKINSONS-DISEASE
    RABEY, JM
    SCHWARTZ, M
    GRAFF, E
    HARSAT, A
    VERED, Y
    CLINICAL NEUROPHARMACOLOGY, 1991, 14 (06) : 514 - 522
  • [36] BROMOCRIPTINE - LONG-TERM LOW-DOSE THERAPY IN PARKINSONS-DISEASE
    TEYCHENNE, PF
    BERGSRUD, D
    ELTON, RL
    RACY, A
    CLINICAL NEUROPHARMACOLOGY, 1986, 9 (02) : 138 - 145
  • [37] BROMOCRIPTINE IN PARKINSONS-DISEASE - A STUDY OF CARDIOVASCULAR EFFECTS
    QUINN, N
    ILLAS, AC
    LHERMITTE, F
    AGID, Y
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1981, 44 (05): : 426 - 429
  • [38] PARKINSONS-DISEASE AND HYPERTENSION - CHRONIC BROMOCRIPTINE TREATMENT
    MONTASTRUC, JL
    CHAMONTIN, B
    RASCOL, A
    NEUROLOGY, 1985, 35 (11) : 1644 - 1647
  • [39] EFFICACY OF SMALL DOSES OF BROMOCRIPTINE IN PARKINSONS-DISEASE
    MYLLYLA, VV
    SAARINEN, A
    YLOSTALO, P
    HOKKANEN, E
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1983, 33 (01): : 144 - 149
  • [40] LISURIDE IN COMPARISON TO BROMOCRIPTINE IN THE TREATMENT OF PARKINSONS-DISEASE
    LAIHINEN, A
    RINNE, UK
    SONNINEN, V
    SUCHY, I
    UPSALA JOURNAL OF MEDICAL SCIENCES, 1986, : 92 - 92
12345